T1	Participants 905 915	14,916 men
T2	Participants 966 975	1,066 men
T3	Participants 1017 1045	496 with aggressive disease,
T4	Participants 1128 1146	1,618 cancer-free,
T5	Participants 1798 1818	control participants
T6	Participants 2007 2010	Men
T7	Participants 2757 2760	men
T8	Participants 2876 2879	men
T9	Participants 3125 3128	men
